(STKL) SunOpta - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: CA8676EP1086

STKL: Plant-based Beverages, Fruit Snacks, Tea, Broths, Ingredients

SunOpta Inc. (NASDAQ: STKL) is a leading manufacturer and distributor of plant-based and fruit-based food and beverage products, operating across the United States, Canada, and international markets. The company specializes in a diverse portfolio of products, including plant-based beverages made from oat, almond, soy, coconut, rice, hemp, and other bases, marketed under the Dream and West Life brands. It also produces oat-based creamers under the SOWN label, ready-to-drink protein shakes, and a variety of nut, grain, seed, and legume-based beverages. Additionally, SunOpta offers packaged teas, meat and vegetable broths, and stocks, catering to the growing demand for natural and organic food options.

The company’s product range extends to plant-based ingredients such as oatbase, oatgold, soybase, hempbase, soypowders, and okara, which are used in both internal production and sold to other food and beverage manufacturers. SunOpta also provides ready-to-eat fruit snacks, including bars, bites, twists, strips, and sandwich formats made from apple puree and juice concentrate, as well as cold-pressed fruit bars. Its ready-to-eat fruit smoothies and chia bowls, topped with frozen fruit, further enhance its presence in the health-conscious consumer market. The company’s distribution channels include private label products for retail customers, branded products under co-manufacturing agreements with other food companies, and its own branded products sold directly to retail and foodservice customers.

Originally known as Stake Technology Ltd., SunOpta Inc. was renamed in 2003 and is headquartered in Eden Prairie, Minnesota. With a market capitalization of $843.44M, the company operates in the Packaged Foods & Meats sub-industry. Its financial metrics reflect a forward P/E ratio of 48.08 and a price-to-sales ratio of 1.19, indicating a valuation aligned with its growth prospects. However, the return on equity (RoE) of -12.09% highlights the challenges the company faces in optimizing profitability despite its revenue growth.

Looking ahead, SunOpta Inc. is well-positioned to capitalize on the accelerating demand for plant-based and natural food products, driven by consumer trends toward healthier and more sustainable diets. The company’s diversified product portfolio and robust distribution network provide a strong foundation for expansion. However, its ability to improve profitability will depend on its capacity to innovate, reduce costs, and enhance operational efficiency. With a forward P/E ratio of 48.08, the market is pricing in significant growth expectations, which the company will need to meet to justify its current valuation. If SunOpta can

Additional Sources for STKL Stock

STKL Stock Overview

Market Cap in USD 572m
Sector Consumer Defensive
Industry Beverages - Non-Alcoholic
GiC Sub-Industry Packaged Foods & Meats
IPO / Inception 1990-03-26

STKL Stock Ratings

Growth 5y 17.9%
Fundamental -29.9%
Dividend 0.0%
Rel. Strength -43.9
Analysts 4.86/5
Fair Price Momentum 3.30 USD
Fair Price DCF 3.34 USD

STKL Dividends

No Dividends Paid

STKL Growth Ratios

Growth Correlation 3m -84.4%
Growth Correlation 12m 32.3%
Growth Correlation 5y -30.6%
CAGR 5y 14.07%
CAGR/Max DD 5y 0.17
Sharpe Ratio 12m -0.91
Alpha -31.04
Beta 1.902
Volatility 48.88%
Current Volume 1572.4k
Average Volume 20d 828k
What is the price of STKL stocks?
As of April 09, 2025, the stock is trading at USD 3.92 with a total of 1,572,364 shares traded.
Over the past week, the price has changed by -16.60%, over one month by -30.25%, over three months by -46.52% and over the past year by -40.79%.
Is SunOpta a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, SunOpta (NASDAQ:STKL) is currently (April 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -29.85 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of STKL as of April 2025 is 3.30. This means that STKL is currently overvalued and has a potential downside of -15.82%.
Is STKL a buy, sell or hold?
SunOpta has received a consensus analysts rating of 4.86. Therefor, it is recommend to buy STKL.
  • Strong Buy: 6
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for STKL stock price target?
According to ValueRays Forecast Model, STKL SunOpta will be worth about 3.7 in April 2026. The stock is currently trading at 3.92. This means that the stock has a potential downside of -6.12%.
Issuer Forecast Upside
Wallstreet Target Price 10.2 159.4%
Analysts Target Price 10.2 159.4%
ValueRay Target Price 3.7 -6.1%